Dose and administration time of indocyanine green in near-infrared fluorescence cholangiography during laparoscopic cholecystectomy (DOTIG): study protocol for a randomised clinical trial

Доза и время введения индоцианина зелёного при флуоресцентной холангиографии в ближнем инфракрасном диапазоне во время лапароскопической холецистэктомии (DOTIG): протокол рандомизированного клинического исследования
Sonsoles Garrosa-Muñoz, Fernando Pardo Aranda, Patricia Rodríguez‐Fortúnez, Clara Gené Škrabec, Ricardo López‐Pérez, Jaime López Sánchez, José Manuel Sánchez-Santos, Luis Muñoz‐Bellvís
2023-03-01

bile duct injuryindocyanine greenlaparoscopic cholecystectomynear-infrared fluorescence cholangiographyrandomised clinical trial
BACKGROUND: One of the most severe complications in laparoscopic cholecystectomy (LC) is intraoperative bile duct injury (BDI). Despite its low incidence, the medical implications for the patient can be serious. Besides, BDI can also generate significant legal issues in healthcare. Different techniques have been described to reduce the incidence of this complication, and near-infrared fluorescence cholangiography with indocyanine green (NIRFC-ICG) is one of the latest additions. In spite of the great interest aroused by this procedure, there are currently great disparities in the usage or administration protocols of ICG. METHODS AND ANALYSIS: This is a randomised, multicentre, per-protocol analysis, open clinical trial with four arms. The estimated duration of the trial is 12 months. The aim of the study is to analyse whether there are differences between the dose and administration ICG intervals to obtain good-quality NIRFC during LC. The primary outcome is the degree of identification of critical biliary structures during LC. In addition, different factors will be analysed that may have an influence on the results of this technique. ETHICS AND DISSEMINATION: The trial will be conducted according to the recommendations for Clinical Trials in the Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects and the recommendations of the Spanish Agency of Medicines and Medical Devices (AEMPs) for clinical trials. This trial was approved by the local institutional Ethics Committee and the AEMPs. The results of the study will be presented to the scientific community through publications, conferences or other means. EUDRACT NUMBER: 2022-000904-36. PROTOCOL VERSION: V.1.4, 2 June 2022 TRIAL REGISTRATION NUMBER: NCT05419947.
1
The primary outcome is the degree to which critical biliary structures are identified during laparoscopic cholecystectomy using near-infrared fluorescence cholangiography.
2
The protocol received approval from the institutional Ethics Committee and Spanish Agency of Medicines and Medical Devices; registration numbers are EUDRACT 2022-000904-36 and NCT05419947.
3
The study will assess whether ICG dose and administration interval affect the quality of near-infrared fluorescence cholangiography and will analyze other influencing factors.
4
The trial addresses substantial variation in indocyanine green dosing and administration timing for near-infrared fluorescence cholangiography during laparoscopic cholecystectomy.
5
This is a randomised, multicentre, open clinical trial with four arms and an estimated 12-month duration.

near-infrared fluorescence cholangiography with indocyanine green during laparoscopic cholecystectomy

the effects of indocyanine green dose and administration timing on the quality of near-infrared fluorescence cholangiography, particularly identification of critical biliary structures

Publication Details
Publication Date
2023-03-01
Journal
Publisher
ISSN
Cited by
19
Access Type
Author Information
Authors
Sonsoles Garrosa-Muñoz
Fernando Pardo Aranda
Patricia Rodríguez‐Fortúnez
Clara Gené Škrabec
Ricardo López‐Pérez
Jaime López Sánchez
José Manuel Sánchez-Santos
Luis Muñoz‐Bellvís
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%